ArticleBreast cancer research : BCR2011

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.

Teresa Puig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.